Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.39 |
| ▸ | ADRA2A known ✓ | P08913 | 1/20 | 0.39 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.39 |
| ▸ | OPRM1 known ✓ | P35372 | 1/20 | 0.39 |
| ▸ | OPRK1 known ✓ | P41145 | 1/20 | 0.39 |
| ▸ | ADRB2 known ✓ | P07550 | 2/20 | 0.38 |
| ▸ | ADRB1 known ✓ | P08588 | 2/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.39 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.39 |
| ▸ | DRD1 | P21728 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tartaric Acid SCHEMBL30358002 | 1.00 | CASP1 (0.42) | CASP1KMT2ACXCL8ROCK2ROCK1 | |
| Cadaverine Tartrate SCHEMBL29771995 | 1.00 | CASP1 (0.42) | CASP1KMT2ACXCL8ROCK2ROCK1 | |
| SCHEMBL1159853 | 0.91 | CASP1 (0.44) | CASP1KMT2ACXCL8ROCK2ROCK1 | |
| SCHEMBL13306848 | 0.91 | CASP1 (0.44) | CASP1KMT2ACXCL8ROCK2ROCK1 | |
| SCHEMBL29557046 | 0.91 | CASP1 (0.44) | CASP1KMT2ACXCL8ROCK2ROCK1 | |
| SCHEMBL29975235 | 0.91 | CASP1 (0.44) | CASP1KMT2ACXCL8ROCK2ROCK1 | |
| SCHEMBL5101666 | 0.91 | CASP1 (0.44) | CASP1KMT2ACXCL8ROCK2ROCK1 | |
| Hydrochloric Acid SCHEMBL30832053 | 0.89 | CASP1 (0.43) | CASP1KMT2ACXCL8ROCK2ROCK1 | |
| Hydrochloric Acid SCHEMBL28793542 | 0.89 | CASP1 (0.43) | CASP1KMT2ACXCL8ROCK2ROCK1 | |
| Hydrochloric Acid SCHEMBL29772137 | 0.89 | CASP1 (0.43) | CASP1KMT2ACXCL8ROCK2ROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6812363-B2 | HEATING WITH THIONYL CHLORIDE; CREATING MATERIAL WITH NEARLY EQUAL STEREOISOMER AMOUNTS FROM WASTE ENRICHED WITH UNWANTED ISOMERS | USV LIMITED (IN) | 2004-11-02 | — | — | US | disclosed |
| US-20040073057-A1 | Racemization of optically active 2-substituted phenyl glycine esters | USV. LTD. (CORPORATION OF INDIA) (IN) | 2004-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040073057-A1 | Racemization of optically active 2-substituted phenyl glycine esters | GLO1, SLC6A5, SLC6A9 | CHRM2 4422/4885ADRA2A 3613/4885HTR2A 2448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.